Skip to content

Evaluation of the effectiveness of co-Analysis of the effectiveness of co-care model in the management of patients with type 2 diabetes: a 36 month observational real world cohort study

An observational real-world cohort study to analyze management outcomes and associated influencing factors in type 2 diabetes patients under co-care management

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079289
Enrollment
Unknown
Registered
2023-12-29
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Test group:Clinicians' first visit, physical examination (height, weight and blood pressure), collection of basic laboratory data, formulation of individualized drug treatment plan, nurse app data ent

Sponsors

The Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged 18-80 (inclusive) 2. voluntarily download the chronic disease data management software system app for joint care and sign the informed consent 3. can come to the common care clinic = 2 times a year 4. can cooperate with doctors to implement medical orders, no serious disease, and life expectancy = 15 years

Exclusion criteria

Exclusion criteria: 1.patients with important organ failure or other serious diseases, including myocardial infarction, severe mental disorder, severe infection or disseminated intravascular coagulation within one year before enrollment; 2.patients with active or inactive malignancies and life expectancy less than one year; 3.patients with communication barriers who cannot fully understand or cooperate; 4.pregnant women, lactating women and women who have a pregnancy plan in the past year;

Design outcomes

Primary

MeasureTime frame
Changes in blood pressure compared to baseline during follow-up for six months or more and the proportion of reaching the standard ;Changes in blood sugar compared to baseline during follow-up for six months or more and the proportion of reaching the standard ;Changes in blood fat compared to baseline during follow-up for six months or more and the proportion of reaching the standard ;

Secondary

MeasureTime frame
Compared with baseline, the incidence of new onset diabetic retinopathy and the incidence of progression of existing diabetic retinopathy;Compared with baseline, the incidence of new onset diabetic nephropathy and the incidence of progression of existing diabetic nephropathy;Compared with baseline, the incidence of new onset diabetic lower extremity arterial disease and the incidence of progression of original diabetic lower extremity arterial disease;Compared with baseline, the incidence of new onset diabetic foot and the incidence of progression of existing diabetic foot;Scoring of Self Management Behavior Scale;Satisfaction scores ;

Countries

China

Contacts

Public ContactBenli Su

The Second Affiliated Hospital of Dalian Medical University

dlbenlisu@163.com+86 189 0411 7988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026